Our research encompasses multiple applications of nanomaterials in point-of care diagnostics and high-throughput high-content screening tools.
We are currently developing a range of platforms for next-generation diagnostics. We have created array-based sensing strategies for detection of liver disease, and are extending this work to cardiac incident diagnosis. Simultaneously, we are developing tools for high-throughput high-content screens for determination of chemotherapeutic mechanisms and infection diagnostics. We are also applying these hypothesis-free sensors to cancer stem cell differentiation, identifying agents that effect novel de-stemming processes.
Learn more at elements.chem.umass.edu/rotellogroup/
- BSc (Honors) Illinois Institute of Technology, 1985
- MPhil Yale University, 1987
- PhD Yale University, 1990
- Postdoctoral Training: NSF Postdoctoral Fellowship MIT, 1990
Our research encompasses multiple applications of nanomaterials in therapeutics and diagnostics, including both nanoparticles and nano/micropatterned surfaces.